▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3905 by analyst upside · 2026-09-27
CSLLY
CSL Limited
Healthcare · Market Cap $60B · P/E 0x
ANALYST PRICE TARGET
+2.7%
implied upside to consensus target
Current Price $31.17
Consensus Target $32.0
Bull Target $32.0
Bear Target $32.0
Analysts Covering 1
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
1
Sell
0
52-Week Low $16.01
52-Week High $36.28
YTD Return +11.2%
FUNDAMENTALS
Market Cap $60B
P/E Ratio (TTM) N/A
Forward P/E 17.9x
EPS (TTM) $-1.34
PEG Ratio N/A
Dividend Yield 2.32%
Revenue (TTM) $15.8B
Profit Margin -16.3%
52-WEEK RANGE
52-Week Low $16.01
52-Week High $36.28
Current Price $31.17
Bear Target $32.0
Bull Target $32.0
● Now $31.17 ● Target $32.0
TRADING DATA
Avg Volume 201K
YTD Return +11.2%
Analyst Count 1
Consensus Hold
Upside to Target +2.7%
Last Updated 2026-09-27

ANALYST SUMMARY

CSL Limited (CSLLY) is currently trading at $31.17 with a Wall Street consensus price target of $32.0, implying potential upside of 2.7% over the next 12 months. 1 analysts currently cover CSLLY, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $32.0, while the most cautious has a target of $32.0.

CSLLY operates in the Healthcare sector with a market capitalisation of $60B. The stock is up 11.2% year-to-date and is currently trading near the upper end of its 52-week range of $16.01 – $36.28.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
15
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →